Glabridin improves autoimmune disease in Trex1-deficient mice by reducing type I interferon production
Jincai Wen, Wenqing Mu, Hui Li, Yulu Yan, Xiaoyan Zhan, Wei Luo, Zhongxia Wang, Wen Kan, Jia Zhao, Siwen Hui, Ping He, Shuanglin Qin, Yingjie Xu, Ping Zhang, Xiaohe Xiao, Guang Xu, Zhaofang Bai · 2023
Read Glabridin improves autoimmune disease in Trex1-deficient mice by reducing type I interferon production by Jincai Wen, Wenqing Mu, Hui Li, Yulu Yan, Xiaoyan Zhan, Wei Luo, Zhongxia Wang, Wen Kan, Jia Zhao, Siwen Hui, Ping He, Shuanglin Qin, Yingjie Xu, Ping Zhang, Xiaohe Xiao, Guang Xu, Zhaofang Bai (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10709943.txt.
Description
Jincai Wen and co-authors test a liquorice compound against an immune alarm that, when stuck on, drives autoimmune disease. The alarm, the cGAS-STING pathway, fires when DNA appears where it should not. Mice missing the Trex1 gene cannot clear stray DNA, so the alarm sounds constantly and the animals sicken. The team screened the compound glabridin in immune cells and in mice.
Glabridin specifically quieted the pathway, lowering the interferon and inflammatory signals it produces, and it eased disease in the Trex1-deficient mice. Mechanistically, the compound blocks the handshake between the STING protein and its partner IRF3, a precise point of intervention. The authors propose glabridin as a candidate therapy for autoimmune diseases driven by this pathway, a class that includes several rare and hard-to-treat conditions.
Catalog record
| CREATOR | Jincai Wen, Wenqing Mu, Hui Li, Yulu Yan, Xiaoyan Zhan, Wei Luo, Zhongxia Wang, Wen Kan, Jia Zhao, Siwen Hui, Ping He, Shuanglin Qin, Yingjie Xu, Ping Zhang, Xiaohe Xiao, Guang Xu, Zhaofang Bai |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |